These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15255559)

  • 21. [Antimicrobial effect of levofloxacin].
    Mitrokhin SD
    Antibiot Khimioter; 2003; 48(11):23-30. PubMed ID: 15106308
    [No Abstract]   [Full Text] [Related]  

  • 22. [Levofloxacin nowadays].
    Sidirenko SV
    Antibiot Khimioter; 2006; 51(1):28-37. PubMed ID: 16734363
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic experience with levofloxacin in pneumonia and COPD].
    Blasi F
    Infez Med; 2009 Dec; 17 Suppl 5():23-8. PubMed ID: 20424533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial.
    Shorr AF; Zadeikis N; Jackson WL; Ramage AS; Wu SC; Tennenberg AM; Kollef MH
    Clin Infect Dis; 2005 Feb; 40 Suppl 2():S123-9. PubMed ID: 15712100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multi-society position paper on the prevention and management of nosocomial and severe infections: the Italian Society for Infectious Diseases, the Italian Multidisciplinary Society of Hospital Infections, the Italian Society of Chemotherapy, the Italian Society of Respiratory Medicine, the Italian Society of Clinical Microbiology, the Italian Society of Microbiology, and GISIG (Italian Study Group on Severe Infections).
    Ippolito G; Carosi G; Moroni M; Nicastri E; Lauria FN; Mazzotta F; Goglio A; Pea F; Blasi F; Fortina G; Rossano F
    Int J Infect Dis; 2010 Oct; 14 Suppl 4():S93-4. PubMed ID: 20708953
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficacy and safety of levofloxacin in low respiratory tract infection].
    Zubkov MN
    Antibiot Khimioter; 2004; 49(5):31-7. PubMed ID: 15573900
    [No Abstract]   [Full Text] [Related]  

  • 27. [Observational study investigating the use of levofloxacin in ICU patients].
    Alvarez-Lerma F; Palomar M; Olaechea P; León C; Sánchez M; Bermejo B;
    Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):220-6. PubMed ID: 15056438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Levofloxacin in complex therapy of patients with skin and soft tissue infections].
    Blatun LA; Terekhova RP
    Antibiot Khimioter; 2008; 53(9-10):32-5. PubMed ID: 19441647
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
    Lee YJ; Liu HY; Lin YC; Sun KL; Chun CL; Hsueh PR
    Int J Antimicrob Agents; 2010 Mar; 35(3):261-4. PubMed ID: 20045290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study.
    von Gottberg A; Klugman KP; Cohen C; Wolter N; de Gouveia L; du Plessis M; Mpembe R; Quan V; Whitelaw A; Hoffmann R; Govender N; Meiring S; Smith AM; Schrag S;
    Lancet; 2008 Mar; 371(9618):1108-13. PubMed ID: 18359074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-adherence to infectious disease consultations: are surgeons to blame?
    Madariaga MG
    J Antimicrob Chemother; 2006 May; 57(5):1019-20. PubMed ID: 16531432
    [No Abstract]   [Full Text] [Related]  

  • 32. Premarketing population pharmacokinetic study of levofloxacin in normal subjects and patients with infectious diseases.
    Tanigawara Y; Nomura H; Kagimoto N; Okumura K; Hori R
    Biol Pharm Bull; 1995 Feb; 18(2):315-20. PubMed ID: 7742805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is levofloxacin as active as ciprofloxacin against Pseudomonas aeruginosa?
    Bonfiglio G
    Chemotherapy; 2001; 47(4):239-42. PubMed ID: 11399859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levofloxacin in patients with severe respiratory tract infection.
    Odagiri S
    Drugs; 1995; 49 Suppl 2():426-7. PubMed ID: 8549387
    [No Abstract]   [Full Text] [Related]  

  • 35. [Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].
    Iakovlev VP; Svetukhin AM; Blatun LA; Ukhin SA
    Antibiot Khimioter; 2004; 49(8-9):57-65. PubMed ID: 15727148
    [No Abstract]   [Full Text] [Related]  

  • 36. [Levofloxacin and other antibacterial drugs].
    Ivanov DV; Budanov SV
    Antibiot Khimioter; 2006; 51(6):27-37. PubMed ID: 17523419
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of pulmonary actinomycosis with levofloxacin.
    Ferreira Dde F; Amado J; Neves S; Taveira N; Carvalho A; Nogueira R
    J Bras Pneumol; 2008 Apr; 34(4):245-8. PubMed ID: 18425262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influences of alternate therapy protocol and continuous infectious disease consultation on antibiotic susceptibility in ICU.
    Akalin H; Kahveci F; Ozakin C; Helvaci S; Gedikoğlu S; Kutlay O; Töre O
    Intensive Care Med; 1999 Sep; 25(9):1010-2. PubMed ID: 10501761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infectious disease consultation and microbiologic surveillance for intensive care unit trauma patients: a pilot study.
    Fox BC; Imrey PB; Voights MB; Norwood S
    Clin Infect Dis; 2001 Dec; 33(12):1981-9. PubMed ID: 11712090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction: infectious diseases in the critically ill.
    Olsen KM; Ng TM
    J Pharm Pract; 2010 Feb; 23(1):5. PubMed ID: 21507787
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.